STRATEGY STUDIO / NONPROFIT PEOPLE SEARCH

CANCER RESEARCH AMERICA NFCR INC: Form 990, tax year 2021

View the entire original 990 at ProPublica ↗

Organization
CANCER RESEARCH AMERICA NFCR INC (EIN 04-2531031)
Tax period
2021-01-01 to 2021-12-31
Filed
2022-09-20
IRS object ID
202202639349301520
Schema version
2021v4.2
Source
Download XML · Original 990 at ProPublica

Every field in the e-filed return. Faint text is the IRS element name, for citing.

Return header ReturnHeader

FieldValueIRS element (for citing)
Return2022-09-20T13:43:32-05:00ReturnTs
Tax Period End2021-12-31TaxPeriodEndDt

Preparer Firm PreparerFirmGrp

Preparer Firm Name PreparerFirmName

FieldValueIRS element (for citing)
Business Name Line1WITHUMSMITHBROWNPCBusinessNameLine1Txt

Preparer US Address PreparerUSAddress

FieldValueIRS element (for citing)
Address Line14600 EAST WEST HWY 900AddressLine1Txt
CityBETHESDACityNm
State AbbreviationMDStateAbbreviationCd
ZIP208143423ZIPCd
FieldValueIRS element (for citing)
Return Type990ReturnTypeCd
Tax Period Begin2021-01-01TaxPeriodBeginDt

Filer Filer

FieldValueIRS element (for citing)
EIN042531031EIN

Business Name BusinessName

FieldValueIRS element (for citing)
Business Name Line1NATIONAL FOUNDATION FOR CANCER RESEARCHBusinessNameLine1Txt
FieldValueIRS element (for citing)
In Care Of% KWOK LEUNGInCareOfNm
Business Name ControlNATIBusinessNameControlTxt
Phone3016541250PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line15515 SECURITY LANE Suite 1105AddressLine1Txt
CityROCKVILLECityNm
State AbbreviationMDStateAbbreviationCd
ZIP20852ZIPCd

Business Officer BusinessOfficerGrp

FieldValueIRS element (for citing)
PersonSUJUAN BAPersonNm
Person TitlePRESIDENT & CEOPersonTitleTxt
Phone3016541250PhoneNum
Signature2022-09-15SignatureDt
Discuss With Paid PreparerYes (true)DiscussWithPaidPreparerInd

Signing Officer SigningOfficerGrp

Person Full Name PersonFullName

FieldValueIRS element (for citing)
Person FirstSUJUANPersonFirstNm
Person LastBAPersonLastNm
FieldValueIRS element (for citing)
SSN999009999SSN

Preparer Person PreparerPersonGrp

FieldValueIRS element (for citing)
Preparer PersonRICHARD RUVELSONPreparerPersonNm
PTINP00234075PTIN
Phone3012726000PhoneNum

Additional Filer Information AdditionalFilerInformation

Trusted Customer TrustedCustomerGrp

FieldValueIRS element (for citing)
Trusted Customer3TrustedCustomerCd
FieldValueIRS element (for citing)
Tax2021TaxYr
Build TS2022-09-23 18:48:47ZBuildTS

Form 990 IRS990

FieldValueIRS element (for citing)
Principal OfficerSUJUAN BAPrincipalOfficerNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line15515 SECURITY LANE SUITE 1105AddressLine1Txt
CityROCKVILLECityNm
State AbbreviationMDStateAbbreviationCd
ZIP20852ZIPCd
FieldValueIRS element (for citing)
Gross Receipts$11,313,185GrossReceiptsAmt
Group Return For AffiliatesfalseGroupReturnForAffiliatesInd
Group Exemption5582GroupExemptionNum
Organization501c3Yes (X)Organization501c3Ind
Website AddressWWW.NFCR.ORGWebsiteAddressTxt
Type Of Organization CorpYes (X)TypeOfOrganizationCorpInd
Formation1973FormationYr
Legal Domicile StateMALegalDomicileStateCd
Activity Or MissionTO SUPPORT CANCER RESEARCH AND PUBLIC EDUCATION RELATING TO PREVENTION, EARLIER DIAGNOSIS, BETTER TREATMENTS AND ULTIMATELY, A CURE FOR CANCER.ActivityOrMissionDesc
Voting Members Governing Body5VotingMembersGoverningBodyCnt
Voting Members Independent5VotingMembersIndependentCnt
Total Employee23TotalEmployeeCnt
Total Volunteers50TotalVolunteersCnt
Total Gross UBI$2,916TotalGrossUBIAmt
Net Unrelated Bus Txbl Incm$1,408NetUnrelatedBusTxblIncmAmt
PY Contributions Grants$10,990,906PYContributionsGrantsAmt
CY Contributions Grants$9,444,496CYContributionsGrantsAmt
PY Program Service Revenue$0PYProgramServiceRevenueAmt
CY Program Service Revenue$0CYProgramServiceRevenueAmt
PY Investment Income$271,161PYInvestmentIncomeAmt
CY Investment Income$464,445CYInvestmentIncomeAmt
PY Other Revenue$203,223PYOtherRevenueAmt
CY Other Revenue$172,312CYOtherRevenueAmt
PY Total Revenue$11,465,290PYTotalRevenueAmt
CY Total Revenue$10,081,253CYTotalRevenueAmt
PY Grants And Similar Paid$4,301,016PYGrantsAndSimilarPaidAmt
CY Grants And Similar Paid$4,293,164CYGrantsAndSimilarPaidAmt
PY Benefits Paid To Members$0PYBenefitsPaidToMembersAmt
CY Benefits Paid To Members$0CYBenefitsPaidToMembersAmt
PY Salaries Comp Emp Bnft Paid$2,652,256PYSalariesCompEmpBnftPaidAmt
CY Salaries Comp Emp Bnft Paid$2,089,022CYSalariesCompEmpBnftPaidAmt
PY Total Prof Fndrsng Expns$66,290PYTotalProfFndrsngExpnsAmt
CY Total Prof Fndrsng Expns$31,140CYTotalProfFndrsngExpnsAmt
CY Total Fundraising Expense$1,534,644CYTotalFundraisingExpenseAmt
PY Other Expenses$3,810,439PYOtherExpensesAmt
CY Other Expenses$3,781,181CYOtherExpensesAmt
PY Total Expenses$10,830,001PYTotalExpensesAmt
CY Total Expenses$10,194,507CYTotalExpensesAmt
PY Revenues Less Expenses$635,289PYRevenuesLessExpensesAmt
CY Revenues Less Expenses-$113,254CYRevenuesLessExpensesAmt
Total Assets BOY$12,283,856TotalAssetsBOYAmt
Total Assets EOY$12,143,234TotalAssetsEOYAmt
Total Liabilities BOY$3,362,374TotalLiabilitiesBOYAmt
Total Liabilities EOY$2,919,358TotalLiabilitiesEOYAmt
Net Assets Or Fund Balances BOY$8,921,482NetAssetsOrFundBalancesBOYAmt
Net Assets Or Fund Balances EOY$9,223,876NetAssetsOrFundBalancesEOYAmt
Info In Schedule O Part IIIYes (X)InfoInScheduleOPartIIIInd
MissionSEE SCHEDULE OMissionDesc
Significant New Program SrvcfalseSignificantNewProgramSrvcInd
Significant ChangefalseSignificantChangeInd
Expense$5,633,275ExpenseAmt
Grant$4,295,664GrantAmt
DescCANCER RESEARCH - SEE SCHEDULE ODesc

Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp

FieldValueIRS element (for citing)
Expense$2,239,455ExpenseAmt
DescCANCER PREVENTION EDUCATION TO THE PUBLIC - SEE SCHEDULE ODesc
FieldValueIRS element (for citing)
Total Program Service Expenses$7,872,730TotalProgramServiceExpensesAmt
Described In Section501c3Yes (true)DescribedInSection501c3Ind
Schedule B RequiredYes (true)ScheduleBRequiredInd
Political Campaign ActyfalsePoliticalCampaignActyInd
Lobbying ActivitiesfalseLobbyingActivitiesInd
Subject To Proxy TaxfalseSubjectToProxyTaxInd
Donor Advised FundYes (true)DonorAdvisedFundInd
Conservation EasementsfalseConservationEasementsInd
Collections Of ArtfalseCollectionsOfArtInd
Credit CounselingfalseCreditCounselingInd
Donor Rstr Or Quasi EndowmentsYes (true)DonorRstrOrQuasiEndowmentsInd
Report Land Building EquipmentYes (true)ReportLandBuildingEquipmentInd
Report Investments Other SecfalseReportInvestmentsOtherSecInd
Report Program Related InvstfalseReportProgramRelatedInvstInd
Report Other AssetsYes (true)ReportOtherAssetsInd
Report Other LiabilitiesYes (true)ReportOtherLiabilitiesInd
Include FIN48 FootnoteYes (true)IncludeFIN48FootnoteInd
Independent Audit Fincl StmtfalseIndependentAuditFinclStmtInd
Consolidated Audit Fincl StmtYes (true)ConsolidatedAuditFinclStmtInd
School OperatingfalseSchoolOperatingInd
Foreign OfficefalseForeignOfficeInd
Foreign ActivitiesYes (true)ForeignActivitiesInd
More Than5000 K To OrgfalseMoreThan5000KToOrgInd
More Than5000 K To IndividualsYes (true)MoreThan5000KToIndividualsInd
Professional FundraisingYes (true)ProfessionalFundraisingInd
Fundraising ActivitiesYes (true)FundraisingActivitiesInd
Gaming ActivitiesfalseGamingActivitiesInd
Operate HospitalfalseOperateHospitalInd
Grants To OrganizationsYes (true)GrantsToOrganizationsInd
Grants To IndividualsYes (true)GrantsToIndividualsInd
Schedule J RequiredYes (true)ScheduleJRequiredInd
Tax Exempt BondsfalseTaxExemptBondsInd
Engaged In Excess Benefit TransfalseEngagedInExcessBenefitTransInd
PY Excess Benefit TransfalsePYExcessBenefitTransInd
Loan OutstandingfalseLoanOutstandingInd
Grant To Related PersonfalseGrantToRelatedPersonInd
Business Rln With Org MemfalseBusinessRlnWithOrgMemInd
Business Rln With Fam MemfalseBusinessRlnWithFamMemInd
Business Rln With35 Ctrl EntfalseBusinessRlnWith35CtrlEntInd
Deductible Non Cash ContriYes (true)DeductibleNonCashContriInd
Deductible Art ContributionfalseDeductibleArtContributionInd
Terminate OperationsfalseTerminateOperationsInd
Partial LiquidationfalsePartialLiquidationInd
Disregarded EntityfalseDisregardedEntityInd
Related EntityYes (true)RelatedEntityInd
Related Organization Ctrl EntYes (true)RelatedOrganizationCtrlEntInd
Transaction With Control EntfalseTransactionWithControlEntInd
Trnsfr Exmpt Non Chrtbl Rltd OrgfalseTrnsfrExmptNonChrtblRltdOrgInd
Activities Conducted PrtshpfalseActivitiesConductedPrtshpInd
Schedule O RequiredYes (true)ScheduleORequiredInd
IRP Document29IRPDocumentCnt
IRP Document W2 G0IRPDocumentW2GCnt
Backup Wthld ComplianceYes (true)BackupWthldComplianceInd
Employee23EmployeeCnt
Employment Tax Returns FiledYes (true)EmploymentTaxReturnsFiledInd
Unrelated Bus Incm Over LimitYes (true)UnrelatedBusIncmOverLimitInd
Form990 T FiledYes (true)Form990TFiledInd
Foreign Financial AccountfalseForeignFinancialAccountInd
Prohibited Tax Shelter TransfalseProhibitedTaxShelterTransInd
Taxable Party NotificationfalseTaxablePartyNotificationInd
Nondeductible ContributionsfalseNondeductibleContributionsInd
Quid Pro Quo ContributionsYes (true)QuidProQuoContributionsInd
Quid Pro Quo Contri DisclYes (true)QuidProQuoContriDisclInd
Form8282 Property Disposed OffalseForm8282PropertyDisposedOfInd
Rcv Fnds To Pay Prsnl Bnft CntrctfalseRcvFndsToPayPrsnlBnftCntrctInd
Pay Premiums Prsnl Bnft CntrctfalsePayPremiumsPrsnlBnftCntrctInd
DAF Excess Business HoldingsfalseDAFExcessBusinessHoldingsInd
Taxable DistributionsfalseTaxableDistributionsInd
Distribution To DonorfalseDistributionToDonorInd
Indoor Tanning ServicesfalseIndoorTanningServicesInd
Subj To Tax Rmnrtn Ex Prcht PymtfalseSubjToTaxRmnrtnExPrchtPymtInd
Subject To Excs Tax Net Invst IncfalseSubjectToExcsTaxNetInvstIncInd
Info In Schedule O Part VIYes (X)InfoInScheduleOPartVIInd
Governing Body Voting Members5GoverningBodyVotingMembersCnt
Independent Voting Member5IndependentVotingMemberCnt
Family Or Business RlnfalseFamilyOrBusinessRlnInd
Delegation Of Mgmt DutiesfalseDelegationOfMgmtDutiesInd
Change To Org DocumentsYes (true)ChangeToOrgDocumentsInd
Material Diversion Or MisusefalseMaterialDiversionOrMisuseInd
Members Or StockholdersYes (true)MembersOrStockholdersInd
Election Of Board MembersfalseElectionOfBoardMembersInd
Decisions Subject To ApprovafalseDecisionsSubjectToApprovaInd
Minutes Of Governing BodyYes (true)MinutesOfGoverningBodyInd
Minutes Of CommitteesYes (true)MinutesOfCommitteesInd
Officer Mailing AddressfalseOfficerMailingAddressInd
Local ChaptersYes (true)LocalChaptersInd
Policies Reference ChaptersYes (true)PoliciesReferenceChaptersInd
Form990 Provided To Gvrn BodyYes (true)Form990ProvidedToGvrnBodyInd
Conflict Of Interest PolicyYes (true)ConflictOfInterestPolicyInd
Annual Disclosure Covered PrsnYes (true)AnnualDisclosureCoveredPrsnInd
Regular Monitoring EnfrcYes (true)RegularMonitoringEnfrcInd
Whistleblower PolicyYes (true)WhistleblowerPolicyInd
Document Retention PolicyYes (true)DocumentRetentionPolicyInd
Compensation Process CEOYes (true)CompensationProcessCEOInd
Compensation Process OtherYes (true)CompensationProcessOtherInd
Investment In Joint VenturefalseInvestmentInJointVentureInd
States Where Copy Of Return Is FldALStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldAKStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldAZStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldARStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCOStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldCTStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldDCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldFLStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldGAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldHIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldILStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldINStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldKSStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldKYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMEStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMDStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMNStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldMSStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNHStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNJStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNMStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNYStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldNDStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldOHStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldOKStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldORStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldPAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldRIStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldSCStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldTNStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldUTStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldVAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWAStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWVStatesWhereCopyOfReturnIsFldCd
States Where Copy Of Return Is FldWIStatesWhereCopyOfReturnIsFldCd
Own WebsiteYes (X)OwnWebsiteInd
Upon RequestYes (X)UponRequestInd

Books In Care Of Detail BooksInCareOfDetail

FieldValueIRS element (for citing)
PersonKWOK LEUNGPersonNm
Phone3016541250PhoneNum

US Address USAddress

FieldValueIRS element (for citing)
Address Line15515 SECURITY LANE SUITE 1105AddressLine1Txt
CityROCKVILLECityNm
State AbbreviationMDStateAbbreviationCd
ZIP20852ZIPCd
FieldValueIRS element (for citing)
Info In Schedule O Part VIIYes (X)InfoInScheduleOPartVIIInd

Form990 Part VII Section A Form990PartVIISectionAGrp (11 entries)

TitleTitleTxtAverage Hours Per WeekAverageHoursPerWeekRtAverage Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRtOfficerOfficerIndReportable Comp From OrgReportableCompFromOrgAmtReportable Comp From Rltd OrgReportableCompFromRltdOrgAmtOther CompensationOtherCompensationAmtHighest Compensated EmployeeHighestCompensatedEmployeeIndIndividual Trustee Or DirectorIndividualTrusteeOrDirectorInd
SUJUAN BA
PRESIDENT/CEO40.02.0Yes (X)$346,959$0$66,025
YI WANG
CHIEF STRTGY OFF. - ALLIANCES40.01.0$209,571$0$26,266Yes (X)
KWOK LEUNG
CFO/SECRETARY40.05.0Yes (X)$186,688$0$28,416
BRIAN WACHTEL
EXECUTIVE DIRECTOR40.00.0$126,180$0$16,613Yes (X)
BRADLEY GILLENWATER
SR. DIR. FOR CORP. OUTREACH40.00.0$111,622$0$20,472Yes (X)
JUDITH P BARNHARD
CHAIR3.00.0Yes (X)$0$0$0Yes (X)
WENDI P DENNARD
TREASURER1.50.0Yes (X)$0$0$0Yes (X)
PADMAKUMAR KAIMAL
DIRECTOR (THRU 10/2021)1.50.0$0$0$0Yes (X)
ALFRED SLANETZ
DIRECTOR1.50.0$0$0$0Yes (X)
EDWARD S WEST
DIRECTOR1.50.0$0$0$0Yes (X)
BRIAN LEYLAND-JONES
DIRECTOR (EFF 10/2021)1.50.0$0$0$0Yes (X)
FieldValueIRS element (for citing)
Total Reportable Comp From Org$981,020TotalReportableCompFromOrgAmt
Tot Reportable Comp Rltd Org$0TotReportableCompRltdOrgAmt
Total Other Compensation$157,792TotalOtherCompensationAmt
Indiv Rcvd Greater Than100 K5IndivRcvdGreaterThan100KCnt
Former Ofcr Employees ListedfalseFormerOfcrEmployeesListedInd
Total Comp Greater Than150 KYes (true)TotalCompGreaterThan150KInd
Compensation From Other SrcsfalseCompensationFromOtherSrcsInd

Contractor Compensation ContractorCompensationGrp (5 entries)

Address Line1ContractorAddress/USAddress/AddressLine1TxtCityContractorAddress/USAddress/CityNmState AbbreviationContractorAddress/USAddress/StateAbbreviationCdZIPContractorAddress/USAddress/ZIPCdServicesServicesDescCompensationCompensationAmt
REDFIELD DIRECT LLC
11422 MIRACLE HILLS DRIVE 450OMAHANE68154LABEL PRINTING$385,032
CALMARK GROUP LLC
6755 S SAYRE AVENUEBEDFORD PARKIL60638MAILSHOP$247,408
CP DIRECT INC
4600 A BOSTON WAYLANHAMMD20706PRINTING SERVICES$240,003
MACKAY MITCHELL ENVELOPE CO
2100 ELM STREET SEMINNEAPOLISMN55414ENVELOPE PRINTING$164,365
MERKLE
7001 COLUMBIA GATEWAY DRIVECOLUMBIAMD21046CONSULTING$106,294
FieldValueIRS element (for citing)
Cntrct Rcvd Greater Than100 K5CntrctRcvdGreaterThan100KCnt
Federated Campaigns$42,179FederatedCampaignsAmt
Fundraising$128,342FundraisingAmt
Government Grants$800,000GovernmentGrantsAmt
All Other Contributions$8,473,975AllOtherContributionsAmt
Noncash Contributions$121,426NoncashContributionsAmt
Total Contributions$9,444,496TotalContributionsAmt
Total Program Service Revenue$0TotalProgramServiceRevenueAmt

Investment Income InvestmentIncomeGrp

FieldValueIRS element (for citing)
Total Revenue Column$245,554TotalRevenueColumnAmt
Exclusion$245,554ExclusionAmt

Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Royalties Revenue RoyaltiesRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$31,344TotalRevenueColumnAmt
Exclusion$31,344ExclusionAmt

Rental Income Or Loss RentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Real$0RealAmt
Personal$0PersonalAmt

Net Rental Income Or Loss NetRentalIncomeOrLossGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Gross Amount Sales Assets GrossAmountSalesAssetsGrp

FieldValueIRS element (for citing)
Securities$1,450,766SecuritiesAmt

Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp

FieldValueIRS element (for citing)
Securities$1,231,875SecuritiesAmt

Gain Or Loss GainOrLossGrp

FieldValueIRS element (for citing)
Securities$218,891SecuritiesAmt

Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp

FieldValueIRS element (for citing)
Total Revenue Column$218,891TotalRevenueColumnAmt
Exclusion$218,891ExclusionAmt
FieldValueIRS element (for citing)
Fundraising Gross Income$0FundraisingGrossIncomeAmt
Contri Rpt Fundraising Event$128,342ContriRptFundraisingEventAmt
Fundraising Direct Expenses$57FundraisingDirectExpensesAmt

Net Incm From Fundraising Evt NetIncmFromFundraisingEvtGrp

FieldValueIRS element (for citing)
Total Revenue Column-$57TotalRevenueColumnAmt
Exclusion-$57ExclusionAmt
FieldValueIRS element (for citing)
Gaming Gross Income$0GamingGrossIncomeAmt
Gaming Direct Expenses$0GamingDirectExpensesAmt

Net Income From Gaming NetIncomeFromGamingGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt
FieldValueIRS element (for citing)
Gross Sales Of Inventory$0GrossSalesOfInventoryAmt
Cost Of Goods Sold$0CostOfGoodsSoldAmt

Net Income Or Loss NetIncomeOrLossGrp

FieldValueIRS element (for citing)
Total Revenue Column$0TotalRevenueColumnAmt

Other Revenue Misc OtherRevenueMiscGrp

FieldValueIRS element (for citing)
DescMAILING LIST RENTALSDesc
Business541800BusinessCd
Total Revenue Column$141,025TotalRevenueColumnAmt
Unrelated Business Revenue$2,916UnrelatedBusinessRevenueAmt
Exclusion$138,109ExclusionAmt
FieldValueIRS element (for citing)
Other Revenue Total$141,025OtherRevenueTotalAmt

Total Revenue TotalRevenueGrp

FieldValueIRS element (for citing)
Total Revenue Column$10,081,253TotalRevenueColumnAmt
Unrelated Business Revenue$2,916UnrelatedBusinessRevenueAmt
Exclusion$633,841ExclusionAmt

Grants To Domestic Orgs GrantsToDomesticOrgsGrp

FieldValueIRS element (for citing)
Total$3,919,496TotalAmt
Program Services$3,919,496ProgramServicesAmt

Grants To Domestic Individuals GrantsToDomesticIndividualsGrp

FieldValueIRS element (for citing)
Total$343,668TotalAmt
Program Services$343,668ProgramServicesAmt

Foreign Grants ForeignGrantsGrp

FieldValueIRS element (for citing)
Total$30,000TotalAmt
Program Services$30,000ProgramServicesAmt

Benefits To Members BenefitsToMembersGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp

FieldValueIRS element (for citing)
Total$628,088TotalAmt
Program Services$447,746ProgramServicesAmt
Management And General$176,212ManagementAndGeneralAmt
Fundraising$4,130FundraisingAmt

Comp Disqual Persons CompDisqualPersonsGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Other Salaries And Wages OtherSalariesAndWagesGrp

FieldValueIRS element (for citing)
Total$1,171,117TotalAmt
Program Services$864,351ProgramServicesAmt
Management And General$149,284ManagementAndGeneralAmt
Fundraising$157,482FundraisingAmt

Pension Plan Contributions PensionPlanContributionsGrp

FieldValueIRS element (for citing)
Total$110,857TotalAmt
Program Services$82,280ProgramServicesAmt
Management And General$11,148ManagementAndGeneralAmt
Fundraising$17,429FundraisingAmt

Other Employee Benefits OtherEmployeeBenefitsGrp

FieldValueIRS element (for citing)
Total$67,276TotalAmt
Program Services$45,851ProgramServicesAmt
Management And General$13,785ManagementAndGeneralAmt
Fundraising$7,640FundraisingAmt

Payroll Taxes PayrollTaxesGrp

FieldValueIRS element (for citing)
Total$111,684TotalAmt
Program Services$81,279ProgramServicesAmt
Management And General$19,806ManagementAndGeneralAmt
Fundraising$10,599FundraisingAmt

Fees For Services Management FeesForServicesManagementGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Fees For Services Legal FeesForServicesLegalGrp

FieldValueIRS element (for citing)
Total$31,122TotalAmt
Management And General$31,122ManagementAndGeneralAmt

Fees For Services Accounting FeesForServicesAccountingGrp

FieldValueIRS element (for citing)
Total$49,131TotalAmt
Management And General$49,131ManagementAndGeneralAmt

Fees For Services Lobbying FeesForServicesLobbyingGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Fees For Services Prof Fundraising FeesForServicesProfFundraising

FieldValueIRS element (for citing)
Total$31,140TotalAmt
Fundraising$31,140FundraisingAmt

Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp

FieldValueIRS element (for citing)
Total$55,984TotalAmt
Management And General$55,984ManagementAndGeneralAmt

Fees For Services Other FeesForServicesOtherGrp

FieldValueIRS element (for citing)
Total$256,502TotalAmt
Program Services$128,996ProgramServicesAmt
Management And General$122,516ManagementAndGeneralAmt
Fundraising$4,990FundraisingAmt

Advertising AdvertisingGrp

FieldValueIRS element (for citing)
Total$30,583TotalAmt
Program Services$4,674ProgramServicesAmt
Management And General$16,515ManagementAndGeneralAmt
Fundraising$9,394FundraisingAmt

Office Expenses OfficeExpensesGrp

FieldValueIRS element (for citing)
Total$110,540TotalAmt
Program Services$30,436ProgramServicesAmt
Management And General$72,996ManagementAndGeneralAmt
Fundraising$7,108FundraisingAmt

Information Technology InformationTechnologyGrp

FieldValueIRS element (for citing)
Total$359,480TotalAmt
Program Services$235,359ProgramServicesAmt
Management And General$4,842ManagementAndGeneralAmt
Fundraising$119,279FundraisingAmt

Royalties RoyaltiesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Occupancy OccupancyGrp

FieldValueIRS element (for citing)
Total$231,992TotalAmt
Program Services$169,133ProgramServicesAmt
Management And General$41,080ManagementAndGeneralAmt
Fundraising$21,779FundraisingAmt

Travel TravelGrp

FieldValueIRS element (for citing)
Total$17,311TotalAmt
Program Services$10,525ProgramServicesAmt
Management And General$6,786ManagementAndGeneralAmt

Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Conferences Meetings ConferencesMeetingsGrp

FieldValueIRS element (for citing)
Total$88,717TotalAmt
Program Services$88,717ProgramServicesAmt

Interest InterestGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Payments To Affiliates PaymentsToAffiliatesGrp

FieldValueIRS element (for citing)
Total$0TotalAmt

Depreciation Depletion DepreciationDepletionGrp

FieldValueIRS element (for citing)
Total$34,410TotalAmt
Program Services$25,075ProgramServicesAmt
Management And General$6,096ManagementAndGeneralAmt
Fundraising$3,239FundraisingAmt

Insurance InsuranceGrp

FieldValueIRS element (for citing)
Total$28,804TotalAmt
Program Services$21,312ProgramServicesAmt
Management And General$4,740ManagementAndGeneralAmt
Fundraising$2,752FundraisingAmt

Other Expenses OtherExpensesGrp (4 entries)

DescDescTotalTotalAmtProgram ServicesProgramServicesAmtFundraisingFundraisingAmtManagement And GeneralManagementAndGeneralAmt
DIRECT MAIL PROGRAMS$2,372,802$1,286,271$1,086,531
LOCK BOX SERVICE$76,709$45,557$31,152
PROCESS FEES-LIST SALES$20,193$12,004$8,189
MISCELLANEOUS FUNDRAISING$14,866$11,811$3,055

All Other Expenses AllOtherExpensesGrp

FieldValueIRS element (for citing)
Total$2,035TotalAmt
Management And General$2,035ManagementAndGeneralAmt

Total Functional Expenses TotalFunctionalExpensesGrp

FieldValueIRS element (for citing)
Total$10,194,507TotalAmt
Program Services$7,872,730ProgramServicesAmt
Management And General$787,133ManagementAndGeneralAmt
Fundraising$1,534,644FundraisingAmt
FieldValueIRS element (for citing)
Joint CostsYes (X)JointCostsInd

Total Joint Costs TotalJointCostsGrp

FieldValueIRS element (for citing)
Total$2,649,178TotalAmt
Program Services$1,607,041ProgramServicesAmt
Fundraising$1,042,137FundraisingAmt

Cash Non Interest Bearing CashNonInterestBearingGrp

FieldValueIRS element (for citing)
BOY$3,062BOYAmt
EOY$4,550EOYAmt

Savings And Temp Cash Invst SavingsAndTempCashInvstGrp

FieldValueIRS element (for citing)
BOY$2,123,510BOYAmt
EOY$2,206,647EOYAmt

Pledges And Grants Receivable PledgesAndGrantsReceivableGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Accounts Receivable AccountsReceivableGrp

FieldValueIRS element (for citing)
BOY$70,919BOYAmt
EOY$87,021EOYAmt

Receivables From Officers Etc ReceivablesFromOfficersEtcGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Inventories For Sale Or Use InventoriesForSaleOrUseGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp

FieldValueIRS element (for citing)
BOY$180,076BOYAmt
EOY$196,004EOYAmt
FieldValueIRS element (for citing)
Land Bldg Equip Cost Or Other Bss$218,655LandBldgEquipCostOrOtherBssAmt
Land Bldg Equip Accum Deprec$182,720LandBldgEquipAccumDeprecAmt

Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp

FieldValueIRS element (for citing)
BOY$67,233BOYAmt
EOY$35,935EOYAmt

Investments Pub Traded Sec InvestmentsPubTradedSecGrp

FieldValueIRS element (for citing)
BOY$5,041,532BOYAmt
EOY$5,538,898EOYAmt

Investments Other Securities InvestmentsOtherSecuritiesGrp

FieldValueIRS element (for citing)
BOY$750,441BOYAmt
EOY$442EOYAmt

Investments Program Related InvestmentsProgramRelatedGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Intangible Assets IntangibleAssetsGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Other Assets Total OtherAssetsTotalGrp

FieldValueIRS element (for citing)
BOY$4,047,083BOYAmt
EOY$4,073,737EOYAmt

Total Assets TotalAssetsGrp

FieldValueIRS element (for citing)
BOY$12,283,856BOYAmt
EOY$12,143,234EOYAmt

Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp

FieldValueIRS element (for citing)
BOY$878,399BOYAmt
EOY$1,340,119EOYAmt

Grants Payable GrantsPayableGrp

FieldValueIRS element (for citing)
BOY$743,885BOYAmt
EOY$228,483EOYAmt

Deferred Revenue DeferredRevenueGrp

FieldValueIRS element (for citing)
BOY$135BOYAmt
EOY$135EOYAmt

Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Escrow Account Liability EscrowAccountLiabilityGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Loans From Officers Directors LoansFromOfficersDirectorsGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp

FieldValueIRS element (for citing)
BOY$0BOYAmt
EOY$0EOYAmt

Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp

FieldValueIRS element (for citing)
BOY$400,000BOYAmt
EOY$200,000EOYAmt

Other Liabilities OtherLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$1,339,955BOYAmt
EOY$1,150,621EOYAmt

Total Liabilities TotalLiabilitiesGrp

FieldValueIRS element (for citing)
BOY$3,362,374BOYAmt
EOY$2,919,358EOYAmt
FieldValueIRS element (for citing)
Organization Follows FASB117Yes (X)OrganizationFollowsFASB117Ind

No Donor Restriction Net Assets NoDonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$5,008,076BOYAmt
EOY$5,208,434EOYAmt

Donor Restriction Net Assets DonorRestrictionNetAssetsGrp

FieldValueIRS element (for citing)
BOY$3,913,406BOYAmt
EOY$4,015,442EOYAmt

Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$8,921,482BOYAmt
EOY$9,223,876EOYAmt

Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp

FieldValueIRS element (for citing)
BOY$12,283,856BOYAmt
EOY$12,143,234EOYAmt
FieldValueIRS element (for citing)
Reconcilation Revenue Expnss-$113,254ReconcilationRevenueExpnssAmt
Net Unrlzd Gains Losses Invst$415,648NetUnrlzdGainsLossesInvstAmt
Method Of Accounting AccrualYes (X)MethodOfAccountingAccrualInd
Accountant Compile Or ReviewfalseAccountantCompileOrReviewInd
FS AuditedYes (true)FSAuditedInd

FS Audited Basis FSAuditedBasisGrp

FieldValueIRS element (for citing)
Consolidated Basis Fincl StmtYes (X)ConsolidatedBasisFinclStmtInd
FieldValueIRS element (for citing)
Audit CommitteeYes (true)AuditCommitteeInd
Federal Grant Audit RequiredfalseFederalGrantAuditRequiredInd

Schedule A IRS990ScheduleA

FieldValueIRS element (for citing)
Public Organization170Yes (X)PublicOrganization170Ind

Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$11,921,451CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$12,714,798CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$9,898,471CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$10,990,906CurrentTaxYearMinus1YearAmt
Current Tax Year$9,446,996CurrentTaxYearAmt
Total$54,972,622TotalAmt

Tax Rev Levied Orgnztnl Bnft170 TaxRevLeviedOrgnztnlBnft170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Govt Furn Srvc Fclts Vl170 GovtFurnSrvcFcltsVl170Grp

FieldValueIRS element (for citing)
Total$0TotalAmt

Total Calendar Year170 TotalCalendarYear170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$11,921,451CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$12,714,798CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$9,898,471CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$10,990,906CurrentTaxYearMinus1YearAmt
Current Tax Year$9,446,996CurrentTaxYearAmt
Total$54,972,622TotalAmt
FieldValueIRS element (for citing)
Substantial Contributors Tot$329,544SubstantialContributorsTotAmt
Public Support Total170$54,643,078PublicSupportTotal170Amt

Gross Investment Income170 GrossInvestmentIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$296,562CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$308,859CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$270,568CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$222,444CurrentTaxYearMinus1YearAmt
Current Tax Year$276,878CurrentTaxYearAmt
Total$1,375,311TotalAmt

Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$647CurrentTaxYearMinus4YearsAmt
Current Tax Year$2,859CurrentTaxYearAmt
Total$3,506TotalAmt

Other Income170 OtherIncome170Grp

FieldValueIRS element (for citing)
Current Tax Year Minus4 Years$284,518CurrentTaxYearMinus4YearsAmt
Current Tax Year Minus3 Years$259,968CurrentTaxYearMinus3YearsAmt
Current Tax Year Minus2 Years$301,733CurrentTaxYearMinus2YearsAmt
Current Tax Year Minus1 Year$192,317CurrentTaxYearMinus1YearAmt
Current Tax Year$135,298CurrentTaxYearAmt
Total$1,173,834TotalAmt
FieldValueIRS element (for citing)
Total Support$57,525,273TotalSupportAmt
Public Support CY1700.94990PublicSupportCY170Pct
Public Support PY1700.95394PublicSupportPY170Pct
Thirty Thr Pct Suprt Tests CY170Yes (X)ThirtyThrPctSuprtTestsCY170Ind

Schedule B IRS990ScheduleB

Contributor Information ContributorInformationGrp

FieldValueIRS element (for citing)
ContributorRESTRICTEDContributorNum

Contributor Business Name ContributorBusinessName

FieldValueIRS element (for citing)
Business Name Line1RESTRICTEDBusinessNameLine1

Contributor US Address ContributorUSAddress

FieldValueIRS element (for citing)
Address Line1RESTRICTEDAddressLine1
Address Line2RESTRICTEDAddressLine2
CityRESTRICTEDCity
StateRESTRICTEDState
ZIP CodeRESTRICTEDZIPCode
FieldValueIRS element (for citing)
Total ContributionsRESTRICTEDTotalContributionsAmt

Schedule D IRS990ScheduleD

FieldValueIRS element (for citing)
Donor Advised Funds Held1DonorAdvisedFundsHeldCnt
Donor Advised Funds Vl EOY$3,040DonorAdvisedFundsVlEOYAmt
Disclosed Org Leg CtrlYes (true)DisclosedOrgLegCtrlInd
Disclosed For Charitable PrpsYes (true)DisclosedForCharitablePrpsInd
Art Public Exhibition AmountsArtPublicExhibitionAmountsGrp
Held Works ArtHeldWorksArtGrp

CY Endwmt Fund CYEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$7,784,738BeginningYearBalanceAmt
Contributions$3,290,006ContributionsAmt
Investment Earnings Or Losses$213,641InvestmentEarningsOrLossesAmt
Other Expenditures$4,098,185OtherExpendituresAmt
End Year Balance$7,190,200EndYearBalanceAmt

CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$7,915,837BeginningYearBalanceAmt
Contributions$3,260,266ContributionsAmt
Investment Earnings Or Losses$193,223InvestmentEarningsOrLossesAmt
Other Expenditures$3,584,588OtherExpendituresAmt
End Year Balance$7,784,738EndYearBalanceAmt

CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$10,396,983BeginningYearBalanceAmt
Contributions$4,136,982ContributionsAmt
Investment Earnings Or Losses$286,710InvestmentEarningsOrLossesAmt
Other Expenditures$6,904,838OtherExpendituresAmt
End Year Balance$7,915,837EndYearBalanceAmt

CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$8,699,102BeginningYearBalanceAmt
Contributions$7,119,860ContributionsAmt
Investment Earnings Or Losses-$271,815InvestmentEarningsOrLossesAmt
Other Expenditures$5,150,164OtherExpendituresAmt
End Year Balance$10,396,983EndYearBalanceAmt

CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp

FieldValueIRS element (for citing)
Beginning Year Balance$8,164,316BeginningYearBalanceAmt
Contributions$3,394,266ContributionsAmt
Investment Earnings Or Losses$213,282InvestmentEarningsOrLossesAmt
Other Expenditures$3,072,762OtherExpendituresAmt
End Year Balance$8,699,102EndYearBalanceAmt
FieldValueIRS element (for citing)
Board Designated Balance EOY0.41870BoardDesignatedBalanceEOYPct
Prmnnt Endowment Balance EOY0.35520PrmnntEndowmentBalanceEOYPct
Term Endowment Balance EOY0.22610TermEndowmentBalanceEOYPct
Endowments Held Unrelated OrgfalseEndowmentsHeldUnrelatedOrgInd
Endowments Held Related OrgfalseEndowmentsHeldRelatedOrgInd
LandLandGrp
BuildingsBuildingsGrp

Leasehold Improvements LeaseholdImprovementsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$26,890OtherCostOrOtherBasisAmt
Depreciation$11,702DepreciationAmt
Book Value$15,188BookValueAmt

Equipment EquipmentGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$146,383OtherCostOrOtherBasisAmt
Depreciation$135,816DepreciationAmt
Book Value$10,567BookValueAmt

Other Land Buildings OtherLandBuildingsGrp

FieldValueIRS element (for citing)
Other Cost Or Other Basis$45,382OtherCostOrOtherBasisAmt
Depreciation$35,202DepreciationAmt
Book Value$10,180BookValueAmt
FieldValueIRS element (for citing)
Total Book Value Land Buildings$35,935TotalBookValueLandBuildingsAmt

Other Assets Org OtherAssetsOrgGrp (2 entries)

DescDescBook ValueBookValueAmt
AMOUNT HELD IN TRUST BY OTHERS$3,033,500
RIGHT OF USE ASSET$1,040,237
FieldValueIRS element (for citing)
Total Book Value Other Assets$4,073,737TotalBookValueOtherAssetsAmt
Federal Income Tax Liability$0FederalIncomeTaxLiabilityAmt

Other Liabilities Org OtherLiabilitiesOrgGrp

FieldValueIRS element (for citing)
DescLEASE LIABILITYDesc
Amt$1,150,621Amt
FieldValueIRS element (for citing)
Total Liability$1,150,621TotalLiabilityAmt
Footnote TextYes (X)FootnoteTextInd

Supplemental Information Detail SupplementalInformationDetail (2 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
PART V, LINE 4 - INTENDED USE OF ENDOWMENT FUNDS:THE PRINCIPAL ACTIVITIES OF NFCR ARE RAISING FUNDS AND FIGHTING CANCER THROUGH RESEARCH IN PREVENTION, EARLIER DIAGNOSTIC TECHNIQUES, MORE EFFECTIVE TREATMENTS AND ULTIMATELY, ACHIEVING ONE OF MEDICINES GREATEST GOALS: CURING CANCER TO SAVE LIVES. THE FOUNDATION FULFILLS THIS MISSION BY FUNDING ACROSS THE WORLD OUTSTANDING SCIENTISTS THAT PIONEER CANCER RESEARCH AND FUNDING CANCER PREVENTION EDUCATION PROGRAMS. THE DESIGNATED NET ASSETS, TEMPORARILY RESTRICTED NET ASSETS, AND PERMANENTLY RESTRICTED NET ASSETS ALL ARE INTENDED TO PROVIDE FUNDING FOR SUCH RESEARCH AND EDUCATION PROGRAMS.
PART X, LINE 2 - FIN 48 FOOTNOTE:Accounting principles generally accepted in the United States of America require management to evaluate income tax positions taken and accrue an income tax liability if the organization has taken an uncertain position that more likely than not would not be sustained upon examination by the Internal Revenue Service. Management has evaluated the income tax positions taken and concluded that as of December 31, 2021 there are no uncertain positions taken or expected to be taken that would require recognition in the consolidated financial statements. The Foundation and affiliates are subject to routine audits by taxing jurisdictions; however, there are currently no audits in progress for any tax periods. In addition, there have been no tax related interest or penalties for the periods presented in these consolidated financial statements. Should such penalties and interest be incurred, the Foundation's policy is to recognize them as general and administrative expenses on the consolidated statements of activities.

Schedule F IRS990ScheduleF

FieldValueIRS element (for citing)
Grant Records MaintainedYes (true)GrantRecordsMaintainedInd

Account Activities Outside US AccountActivitiesOutsideUSGrp (2 entries)

RegionRegionTxtOfficesOfficesCntEmployeeEmployeeCntType Of Activities ConductedTypeOfActivitiesConductedTxtRegion Total ExpendituresRegionTotalExpendituresAmt
Europe (Including Iceland and Greenland)00Grantmaking$5,000
East Asia and the Pacific00Grantmaking$25,000
FieldValueIRS element (for citing)
Subtotal Offices0SubtotalOfficesCnt
Subtotal Employees0SubtotalEmployeesCnt
Total Office0TotalOfficeCnt
Total Employee0TotalEmployeeCnt
Subtotal Spent$30,000SubtotalSpentAmt
Total Spent$30,000TotalSpentAmt

Foreign Individuals Grants ForeignIndividualsGrantsGrp (2 entries)

Type Of AssistanceTypeOfAssistanceTxtRegionRegionTxtRecipientRecipientCntCash GrantCashGrantAmtManner Of Cash DisbursementMannerOfCashDisbursementTxt
RESEARCH REVIEWEurope (Including Iceland and Greenland)1$5,000CHECK
RESEARCH REVIEWEast Asia and the Pacific3$25,000CHECK
FieldValueIRS element (for citing)
Transfer To Foreign CorpfalseTransferToForeignCorpInd
Interest In Foreign TrustfalseInterestInForeignTrustInd
Foreign Corp OwnershipfalseForeignCorpOwnershipInd
Passive Foreign Investmest CofalsePassiveForeignInvestmestCoInd
Foreign PartnershipfalseForeignPartnershipInd
Boycott CountriesfalseBoycottCountriesInd

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINE 2FormAndLineReferenceDesc
ExplanationProcedure for monitoring use of grants outside USA: Grant and Contract recipients are required to submit quarterly expenditure reports and annual progress reports to NFCR.ExplanationTxt

Schedule G IRS990ScheduleG

FieldValueIRS element (for citing)
Mail SolicitationsYes (X)MailSolicitationsInd
Email SolicitationsYes (X)EmailSolicitationsInd
Phone SolicitationsYes (X)PhoneSolicitationsInd
In Person SolicitationsYes (X)InPersonSolicitationsInd
Solicitation Of Non Govt GrantsYes (X)SolicitationOfNonGovtGrantsInd
Solicitation Of Govt GrantsYes (X)SolicitationOfGovtGrantsInd
Special Fundraising EventsYes (X)SpecialFundraisingEventsInd
Agrmt Prof Fundraising ActyYes (true)AgrmtProfFundraisingActyInd

Fundraiser Activity Info FundraiserActivityInfoGrp

FieldValueIRS element (for citing)
PersonMERKLE INCPersonNm

US Address USAddress

FieldValueIRS element (for citing)
Address Line17001 COLUMBIA GATEWAY DRIVEAddressLine1Txt
CityCOLUMBIACityNm
State AbbreviationMDStateAbbreviationCd
ZIP21046ZIPCd
FieldValueIRS element (for citing)
ActivityDIRECT MAIL COUNSELActivityTxt
Fundraiser Control Of FundsfalseFundraiserControlOfFundsInd
Gross Receipts$4,048,423GrossReceiptsAmt
Retained By Contractor$31,140RetainedByContractorAmt
Net To Organization$4,017,283NetToOrganizationAmt
FieldValueIRS element (for citing)
Total Gross Receipts$4,048,423TotalGrossReceiptsAmt
Total Retained By Contractors$31,140TotalRetainedByContractorsAmt
Total Net To Organization$4,017,283TotalNetToOrganizationAmt
Licensed StatesALLicensedStatesCd
Licensed StatesAKLicensedStatesCd
Licensed StatesAZLicensedStatesCd
Licensed StatesARLicensedStatesCd
Licensed StatesCALicensedStatesCd
Licensed StatesCOLicensedStatesCd
Licensed StatesCTLicensedStatesCd
Licensed StatesDCLicensedStatesCd
Licensed StatesFLLicensedStatesCd
Licensed StatesGALicensedStatesCd
Licensed StatesHILicensedStatesCd
Licensed StatesILLicensedStatesCd
Licensed StatesINLicensedStatesCd
Licensed StatesKSLicensedStatesCd
Licensed StatesKYLicensedStatesCd
Licensed StatesMELicensedStatesCd
Licensed StatesMDLicensedStatesCd
Licensed StatesMALicensedStatesCd
Licensed StatesMILicensedStatesCd
Licensed StatesMNLicensedStatesCd
Licensed StatesMOLicensedStatesCd
Licensed StatesNHLicensedStatesCd
Licensed StatesNJLicensedStatesCd
Licensed StatesNMLicensedStatesCd
Licensed StatesNYLicensedStatesCd
Licensed StatesNCLicensedStatesCd
Licensed StatesNDLicensedStatesCd
Licensed StatesOHLicensedStatesCd
Licensed StatesOKLicensedStatesCd
Licensed StatesORLicensedStatesCd
Licensed StatesPALicensedStatesCd
Licensed StatesRILicensedStatesCd
Licensed StatesSCLicensedStatesCd
Licensed StatesTNLicensedStatesCd
Licensed StatesUTLicensedStatesCd
Licensed StatesVALicensedStatesCd
Licensed StatesWALicensedStatesCd
Licensed StatesWVLicensedStatesCd
Licensed StatesWYLicensedStatesCd

Fundraising Event Information FundraisingEventInformationGrp

FieldValueIRS element (for citing)
Event1PLAY 4 THE CUREEvent1Nm
Gross Receipts Event1$104,053GrossReceiptsEvent1Amt
Charitable Contri Event1$104,053CharitableContriEvent1Amt
Other Direct Expenses Event1$57OtherDirectExpensesEvent1Amt
Event2DC GOLFEvent2Nm
Gross Receipts Event2$7,652GrossReceiptsEvent2Amt
Charitable Contri Event2$7,652CharitableContriEvent2Amt
Other Events Total5OtherEventsTotalCnt
Gross Receipts Other Events$16,637GrossReceiptsOtherEventsAmt
Charitable Contri Other Events$16,637CharitableContriOtherEventsAmt
Gross Receipts Total$128,342GrossReceiptsTotalAmt
Charitable Contributions Tot$128,342CharitableContributionsTotAmt
Oth Direct Expnss Total Events$57OthDirectExpnssTotalEventsAmt
Direct Expense Summary Events$57DirectExpenseSummaryEventsAmt
Net Income Summary-$57NetIncomeSummaryAmt

Schedule I IRS990ScheduleI

FieldValueIRS element (for citing)
Grant Records MaintainedYes (true)GrantRecordsMaintainedInd

Recipient Table RecipientTable (7 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdRecipient EINRecipientEINIRC SectionIRCSectionDescCash GrantCashGrantAmtPurpose Of GrantPurposeOfGrantTxtNon Cash AssistanceNonCashAssistanceAmtValuation Method UsedValuationMethodUsedDescNon Cash AssistanceNonCashAssistanceDescAddress Line2USAddress/AddressLine2Txt
THE SCRIPPS RESEARCH INSTITUTE
10550 N TORREY PINES RDLA JOLLACA92037330435954501(c)(3)$100,000RESEARCH CONTRACTS
VIRGINIA COMMONWEALTH UNIVERSITY
PO BOX 980568RICHMONDVA23298546001758501(C)(3)$100,000RESEARCH CONTRACTS$15,000FMVCHEMICALS & MATERIAL
KUMC RESEARCH INSTITUTE INC
3901 RAINBOW BLVDKANSAS CITYKS66103481108830501(c)(3)RESEARCH CONTRACTS$20,700FMVCHEMICALS & MATERIALMAIL STOP 1039
UNIVERSITY OF PENNSYLVANIA
3451 WALNUT STPHILADELPHIAPA19104231352685501(C)(3)$19,104RESEARCH CONTRACTS
WAKE FOREST UNIVERSITY HEALTH SCIENCES
MEDICAL CENTER BLVDWINSTONSALEMNC27157223849199501(C)(3)RESEARCH CONTRACTS$60,000FMVCHEMICALS & MATERIAL
GLOBAL COALITION FOR ADAPTIVE RESEARCH INC
PO BOX 427LEXINGTONMA02420821199380501(C)(3)$250,000RESEARCH CONTRACTS
AIM HI ACCELERATOR FUND
5515 SECURITY LN 1105ROCKVILLEMD20852824322538501(C)(3)$1,050,000TRANSLATIONAL$2,375,000BOOK VALUESECURITIES
FieldValueIRS element (for citing)
Total501c3 Org7Total501c3OrgCnt
Total Other Org0TotalOtherOrgCnt

Grants Other Asst To Indiv In US GrantsOtherAsstToIndivInUSGrp (4 entries)

Grant TypeGrantTypeTxtRecipientRecipientCntCash GrantCashGrantAmt
CANCER RESEARCH3$139,918
RESEARCH REVIEW5$68,750
FELLOWSHIP1$90,000
AWARDS FOR CANCER RESEARCH PROGRESSION2$45,000

Supplemental Information Detail SupplementalInformationDetail

FieldValueIRS element (for citing)
Form And Line ReferencePART I, LINE 2 - PROCEDURES FOR MONITORING USE OF GRANT FUNDS IN USA:FormAndLineReferenceDesc
ExplanationGRANT AND CONTRACT RECIPIENTS ARE REQUIRED TO SUBMIT QUARTERLY EXPENDITURE REPORTS AND ANNUAL PROGRESS REPORTS TO NFCR.ExplanationTxt

Schedule J IRS990ScheduleJ

FieldValueIRS element (for citing)
Compensation CommitteeYes (X)CompensationCommitteeInd
Independent ConsultantYes (X)IndependentConsultantInd
Form990 Of Other OrganizationsYes (X)Form990OfOtherOrganizationsInd
Compensation SurveyYes (X)CompensationSurveyInd
Board Or Committee ApprovalYes (X)BoardOrCommitteeApprovalInd
Severance PaymentfalseSeverancePaymentInd
Supplemental Nonqual Rtr PlanfalseSupplementalNonqualRtrPlanInd
Equity Based Comp ArrngmfalseEquityBasedCompArrngmInd
Comp Based On Revenue Of Flng OrgfalseCompBasedOnRevenueOfFlngOrgInd
Comp Bsd On Rev Related OrgsfalseCompBsdOnRevRelatedOrgsInd
Comp Bsd Net Earns Flng OrgfalseCompBsdNetEarnsFlngOrgInd
Comp Bsd Net Earns Rltd OrgsfalseCompBsdNetEarnsRltdOrgsInd
Any Non Fixed PaymentsfalseAnyNonFixedPaymentsInd
Initial Contract ExceptionfalseInitialContractExceptionInd

Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (3 entries)

TitleTitleTxtBase Compensation Filing OrgBaseCompensationFilingOrgAmtCompensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmtBonus Filing OrganizationBonusFilingOrganizationAmountBonus Related OrganizationsBonusRelatedOrganizationsAmtOther Compensation Filing OrgOtherCompensationFilingOrgAmtOther Compensation Rltd OrgsOtherCompensationRltdOrgsAmtDeferred Compensation Flng OrgDeferredCompensationFlngOrgAmtDeferred Comp Rltd OrgsDeferredCompRltdOrgsAmtNontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmtNontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmtTotal Compensation Filing OrgTotalCompensationFilingOrgAmtTotal Compensation Rltd OrgsTotalCompensationRltdOrgsAmtComp Report Prior990 Filing OrgCompReportPrior990FilingOrgAmtComp Report Prior990 Rltd OrgsCompReportPrior990RltdOrgsAmt
SUJUAN BA
PRESIDENT/CEO$346,185$0$0$0$774$0$53,000$0$13,025$0$412,984$0$0$0
YI WANG
CHIEF STRTGY OFF. - ALLIANCES$208,383$0$0$0$1,188$0$25,055$0$1,211$0$235,837$0$0$0
KWOK LEUNG
CFO/SECRETARY$185,500$0$0$0$1,188$0$27,825$0$591$0$215,104$0$0$0

Schedule M IRS990ScheduleM

FieldValueIRS element (for citing)
Works Of ArtWorksOfArtGrp
Art Historical TreasuresArtHistoricalTreasuresGrp
Art Fractional InterestArtFractionalInterestGrp
Books And PublicationsBooksAndPublicationsGrp
Clothing And Household GoodsClothingAndHouseholdGoodsGrp
Cars And Other VehiclesCarsAndOtherVehiclesGrp
Boats And PlanesBoatsAndPlanesGrp
Intellectual PropertyIntellectualPropertyGrp

Securities Publicly Traded SecuritiesPubliclyTradedGrp

FieldValueIRS element (for citing)
Non Cash CheckboxYes (X)NonCashCheckboxInd
Noncash Contributions Rpt F990$20,739NoncashContributionsRptF990Amt
Method Of Determining Revenuesstock market valueMethodOfDeterminingRevenuesTxt
FieldValueIRS element (for citing)
Securities Closely Held StockSecuritiesCloselyHeldStockGrp
Secur Prtnrshp Trust IntrstsSecurPrtnrshpTrustIntrstsGrp
Securities MiscellaneousSecuritiesMiscellaneousGrp
Qualified Contrib Hist StructQualifiedContribHistStructGrp
Qualified Contrib OtherQualifiedContribOtherGrp
Real Estate ResidentialRealEstateResidentialGrp
Real Estate CommercialRealEstateCommercialGrp
Real Estate OtherRealEstateOtherGrp
CollectiblesCollectiblesGrp
Food InventoryFoodInventoryGrp
Drugs And Medical SuppliesDrugsAndMedicalSuppliesGrp
TaxidermyTaxidermyGrp
Historical ArtifactsHistoricalArtifactsGrp
Scientific SpecimensScientificSpecimensGrp
Archaeological ArtifactsArchaeologicalArtifactsGrp

Other Non Cash Contri Table OtherNonCashContriTableGrp

FieldValueIRS element (for citing)
Non Cash CheckboxYes (X)NonCashCheckboxInd
DescCHEMICALS & MATERIALSDesc
Contribution4ContributionCnt
Noncash Contributions Rpt F990$100,687NoncashContributionsRptF990Amt
Method Of Determining RevenuesDONOR'S REPORTED VALMethodOfDeterminingRevenuesTxt
FieldValueIRS element (for citing)
Any Property That Must Be HeldfalseAnyPropertyThatMustBeHeldInd
Review Process Unusual NC GiftsYes (true)ReviewProcessUnusualNCGiftsInd
Third Parties UsedfalseThirdPartiesUsedInd

Schedule O IRS990ScheduleO

Supplemental Information Detail SupplementalInformationDetail (9 entries)

Form And Line ReferenceFormAndLineReferenceDescExplanationExplanationTxt
PART III, LINE 1 - ORGANIZATION'S MISSION:The National Foundation for Cancer Research (NFCR) is a leading public charity dedicated to funding cancer research and public education relating to cancer prevention, earlier diagnosis, better treatments and, ultimately, cures for cancer. NFCR has distinguished itself in the cancer research sector by emphasizing long-term, transformative research often overlooked by other major funding sources. NFCR promotes and facilitates collaboration among scientists to accelerate the pace of discovery from bench to bedside. Since 1973, NFCR has provided more than $400 million in support of discovery-oriented cancer research focused on understanding how and why cells become cancerous, and on public education relating to cancer prevention, detection, and treatment. NFCR is committed to fighting cancer by funding high-risk, high-impact, and potentially high-reward discoveries in the labs and transforming them into life-saving treatments for cancer patients. Through global collaboration, NFCR is making unique impacts on new, accelerated paths to a cure. NFCR envisions a world without cancer! NFCR-FUNDED RESEARCHERS ARE MAKING PROGRESS EVERY DAY IN THEIR PURSUIT OF CANCER CURES, AND THIS IS ONLY POSSIBLE WITH THE FINANCIAL SUPPORT FROM OUR DONORS. ONE STEP AT A TIME, WE ARE GETTING CLOSER TO OUR ULTIMATE GOAL-CURING CANCER, ALL TYPES OF CANCER. FOR MORE INFORMATION, PLEASE VISIT WWW.NFCR.ORG.
PART III, LINE 4A - CANCER RESEARCH PROGRM ACCOMPLISHMENTS:HIGHLIGHTS OF RESEARCH ACCOMPLISHMENTS ====================================== With support from our generous donors, NFCR-funded scientists have made numerous remarkable advances in the fight against cancer. Their research encompasses a wide variety of fields, many of which could ultimately lead to a cure for this deadly disease. Racial Disparity Research in Lung Cancer ---------------------------------------- Wei Zhang, Ph.D. found African American lung cancer patients have different mutations in key cancer-related genes than Caucasian patients, contributing to the increased incidence and lower survival rates in African Americans. The Zhang team won a larger national grant to study more patients, which may lead to life-saving treatments to reduce racial disparity in lung cancer survival rates. Predicting Why Cancer Spreads in Some Patients ---------------------------------------------- Danny Welch, Ph.D. is finding variabilities in the cell part that produces our body's energy, possibly explaining why cancer spreads in some patients but not in others. This may partially explain racial disparities in cancer rates and severity. His team's research suggests a simple blood test could guide doctors to aggressively treat patients whose cancer may spread, or spare patients at low risk from undergoing treatment side effects. Propelling Development of a New Immunotherapy --------------------------------------------- With NFCR discovery research funds, Paul Fisher, M.Ph., Ph.D. advanced his powerful immune-stimulating agent as a new treatment to stop the spread of different types of cancer. NFCR's AIM-HI Translational Research Initiative awarded additional support to bridge the gap between discovery research and expensive clinical drug development required for FDA approval. This year, the AIM-HI funds were matched from another non-profit. Together - we are propelling research forward, giving patients hope for a cure. Benefits of Tumor Microenvironment Research ------------------------------------------- Rakesh Jain, Ph.D. advanced his renowned research on the environment around tumors and our immune system. His team demonstrated exercise in breast cancer brings cancer-killing immune cells into tumors, resensitizing cancer to immunotherapy! They also applied a model for cancer therapy based on inflammation and the immune system - to make COVID-19 treatments more effective. These findings have significant implications for improving treatment efficacy and patient survival. Botanical Drug Treating Patients in Clinical Trials --------------------------------------------------- Over two decades of funding from NFCR supporters helped Yung-Chi Cheng, Ph.D. and his team develop YIV-906, a botanical drug with multiple anti-cancer properties that enhance immunotherapy and chemotherapy. NFCR's AIM-HI Translational Research Initiative support facilitated the translation of YIV-906 reach the clinical stages. Now, a global clinical trial is treating liver cancer patients with YIV-906 combined with a frontline drug. Since YIV-906 also protects the gastrointestinal tract from harsh side effects of many therapies, the botanical should alleviate adverse effects of the frontline drug that has caused many patients to discontinue its use. With success in final phase clinical trials, YIV-906 could become the first U.S.-approved botanical cancer drug-a remarkable achievement. Unique Clinical Trial Gives Hope to Brain Cancer Patients --------------------------------------------------------- A revolutionary clinical trial model, GBM AGILE, is now available to treat patients with the deadliest brain cancer, glioblastoma (GBM). Patients who have not had a new effective treatment in decades, now have hope for survival. GBM AGILE's unique design surpasses standard trials to efficiently evaluate multiple new drugs and drug combinations simultaneously. Benefits include lower cost, reduced time, and fewer patients required to evaluate potential new therapies. Three experimental therapies are available for "treatment arms" in GBM AGILE. In 2021, more than 35 U.S. cancer centers were open to treat patients in the U.S. and Canada. Trial expansion in Europe and China is underway. Since its opening in June 2019 UNITL END OF 2021, GBM AGILE trial has screened 965 patients into the treatment arms. Enrollment rates are 3 to 4 times greater than traditional GBM studies. NFCR has been a pioneer and founding supporter of GBM AGILE. We are also a strategic partner of the Global Coalition for Adaptive Research (GCAR), the official nonprofit sponsor of GBM AGILE. This uniquely designed clinical trial platform is now being utilized to rapidly test new treatments COVID-19 and in the future for other cancers. Launching New Research Program: Restoring Sight for Eye Cancer Patients ----------------------------------------------------------------------- Cancer can damage the eye's retina and cause blindness. With your support, NFCR is now funding the pioneering research of ophthalmologists, Dr. Jean Bennett and Dr. Katherine Uyhazi. Dr. Bennett developed the first FDA-approved gene therapy for a genetic disease, restoring retinal genes and vision in childhood blindness! Together, Drs. Bennett and Uyhazi will now use both gene and cell replacement therapy, two necessities to restore critical retinal components damaged in eye cancer. Your support will impact eye cancer patients as well as those with other eye diseases, giving new hope that their sight may be saved. New Treatment for Childhood Cancer ---------------------------------- Lack of therapies made specifically for young patients forces pediatric oncologists to use adult cancer drugs. In addition to debilitating side effects that can last a lifetime, there are many forms of childhood cancer whose outlook is poor. Unfortunately, financial investment to develop specific pediatric cancer drugs has been dismal. NFCR's AIM-HI Translational Research Initiative supports a pipeline to develop treatments for the most common pediatric cancers with the worst outcome. Volasertib is the pipeline's first drug and will soon reach clinical trials to treat rhabdomyosarcoma, a rare and deadly childhood cancer affecting 450 new patients yearly. Volasertib has the FDA Rare Pediatric Disease Designation to fast-track the drug approval process. Volasertib also has from the FDA Orphan Drug Designation (for diseases that affect less than 200,000 individuals) that provides tax credits to reduce clinical trial costs and a waiver of new drug application fees - saving developers of volasertib nearly $2.9 million dollars. These benefits will save precious time and money for patients, doctors and drug developers. Your commitment to funding this unmet medical need for better treatments is making a difference in the lives of children! NFCR'S CANCER PATIENT TREATMENT ASSISTANCE ------------------------------------------ A cancer diagnosis comes with panic, confusion, uncertainty and many questions: what tests should be scheduled, what are the best treatment options, and are there clinical trials for a new therapy that are suitable to the patient's cancer. NFCR understands the patient's frustrations and needs, and we provide assistance through the difficult time by linking a person in need with the Cancer Patient Treatment Assistance, where one may receive expert professional help from our oncologists. . Understanding the diagnosis and treatment options . Recommend top oncologists to meet specific needs and coordinate the referral process . Identify clinical trials of the newest therapies for advanced cancer or rare tumors for which no standard care or effective therapy is available This medical advice is provided as a resource for patients to consult with their medical team.
PART III, LINE 4B - CANCER PREVENTION EDUCATION TO THE PUBLIC:NFCR provides the public with free materials containing valuable information on the most up-to-date cancer preventive measures, treatment options, and diagnostic tools. Our powerful message has been mailed annually to households, reaching over 266,000 email subscribers and tens of thousands of individuals through our social media channels (Twitter and Facebook) and through our website and blogs, helps to assure that fewer of today's healthy individuals will get cancer and more of today's cancer patients will become tomorrow's cancer survivors. Our public education materials include early cancer detection guide, cancer prevention kits, recipes for healthy living, electronic and printed newsletters, the latest cancer headlines, and in-depth online cancer information.
PART VI, SECTION A, LINE 4 - AMENDMENTS TO GOVERNING DOCUMENTS:NFCR AMENDED THEIR BYLAWS IN 2021: 1. INCREASED THE TERM OF OFFICERS FROM ONE YEAR TO THREE YEARS. 2. ADDED TO LIST OF CORPORATE OFFICERS THE TITLE OF CHAIRPERSON AND VICE CHAIRPERSON. 3. THE CORPORATE OFFICERS SHALL BE CHOSEN ANNUALLY BY THE BOARD OF DIRECTORS EXCEPT FOR THOSE HOLDING POSITIONS AS PRESIDENT AND CHIEF EXECUTIVE OFFICER, THE EXECUTIVE VICE-PRESIDENT, AND CHIEF OPERATING OFFICER WHOSE TERMS ARE GOVERNED INSTEAD BY THEIR EMPLOYMENT WITH THE FOUNDATION.
PART VI, SECTION B, LINE 11B - REVIEW PROCESS OF FORM 990:THE NATIONAL FOUNDATION FOR CANCER RESEARCH'S PROCESS FOR REVIEWING THE FORM 990. ======================================================================== 1. FORM 990 WILL BE PREPARED AFTER ANNUAL AUDIT IS DONE. 2. THE FIRST DRAFT WILL BE REVIEWED BY THE CHIEF OPERATING OFFICER AND THE CHIEF FINANCIAL OFFICER. 3. AFTER RESOLVING ANY QUESTIONS OR UPDATES, THE REVISED DRAFT WILL BE SENT TO BOARD MEMBERS, PREFERABLY ELECTRONICALLY FOR THEIR REVIEW AND COMMENTS. 4. THE BOARD MEMBER'S COMMENTS, IF ANY, WILL BE INCORPORATED IN THE FINAL RETURN. 5. THE RETURN WILL BE FILED WITH THE IRS PRIOR TO THE DESIGNATED DUE DATE OR EXTENDED DUE DATE. 6. THE STATE VERSION WILL BE PROVIDED TO STATES FOR REGISTRATION RENEWALS AND THE PUBLIC PORTIONS OF THE RETURN WILL BE POSTED ON THE FOUNDATION'S WEBSITE. 7. IN THE OCCASION THAT THERE IS INSUFFIENT TIME PRIOR TO FILING FORM 990 TO SHARE IT WITH THE BOARD, OR THERE IS ABSENCE OF AN OPPORTUNITY FOR ANY MEANINGFUL REVIEW OF FORM 990 BY THE BOARD PRIOR TO THE FILINGS DEADLINE, AN ELECTRONIC VERSION OF THE FILED RETURN WILL BE AVAILABLE FOR BOARD MEMBERS' REVIEW AND COMMENTS AFTER SUBMISSION OF RETURN TO IRS. AN AMENDED RETURN, IF NECESSARY, WILL BE FILED.
PART VI, SECTION B, LINE 12C - CONFLICT OF INTEREST POLICY COMPLIANCE:EACH DIRECTOR, PRIOR TO TAKING HIS/HER POSITION ON THE BOARD, AND ALL PRESENT DIRECTORS SHALL SUBMIT IN WRITING TO THE CHAIRMAN OF THE BOARD A LIST OF ALL BUSINESSES OR OTHER ORGANIZATIONS OF WHICH HE/SHE IS AN OFFICER, DIRECTOR, TRUSTEE, MEMBER, OWNER SHAREHOLDER, EMPLOYEE OR AGENT, WITH WHICH THE FOUNDATION HAS, OR MIGHT REASONABLE IN THE FUTURE ENTER INTO, A RELATIONSHIP OR A TRANSACTION IN WHICH THE DIRECTOR WOULD HAVE CONFLICTING INTEREST ANNUALLY.
PART VI, SECTION B, LINE 15A/15B - OFFICERS COMPENSATION:ON AN ANNUAL BASIS, THE BOARD WILL PERFORM A THOROUGH REVIEW TO DETERMINE SUITABLE COMPENSATION. THIS PROCESS INCLUDES ALL OF THE FOLLOWING THREE ELEMENTS. ======================================================================= 1. REVIEW AND APPROVAL BY BOARD OF DIRECTORS: THE COMPENSATION OF EACH OFFICER IS REVIEWED AND APPROVED BY THE BOARD OF DIRECTORS, PROVIDED THAT PERSONS WITH CONFLICTS OF INTEREST WITH RESPECT TO THE COMPENSATION ARRANGEMENT AT ISSUE ARE NOT INVOLVED IN THIS REVIEW AND APPROVAL. EACH OFFICER'S PERFORMANCE IS EVALUATED BASED ON HIS OR HER JOB RESPONSIBILITIES, AND INTERNAL AND EXTERNAL GOALS SET IN THE PREVIOUS YEAR. 2. REVIEW OF "COMPARABLE COMPENSATION" DATA: THE COMPENSATION OF EACH OFFICER IS REVIEWED AND APPROVED USING DATA AS TO COMPARABLE COMPENSATION FOR SIMILARLY QUALIFIED PERSONS IN FUNCTIONALLY COMPARABLE POSITIONS AT SIMILARLY SITUATED ORGANIZATIONS. COMPARABLE DATA ARE COMPILED BY THE FOUNDATION'S CHIEF FINANCIAL OFFICER AND/OR BY OUTSIDE COMPENSATION CONSULTANTS. COMPARABILITY DATA CAN INCLUDE COMPENSATION DATA FROM IRS FORM 990'S OF SIMILAR ORGANIZATIONS, PUBLISHED COMPENSATION SURVEYS, STUDIES AND GUIDES, AND OTHER SOURCES DEEMED APPROPRIATE AT THE TIME. 3. DOCUMENTATION AND RECORDKEEEPING: THERE IS CONTEMPORANEOUS DOCUMENTATION AND RECORDKEEPING WITH RESPECT TO THE DELIBERATIONS AND DECISIONS REGARDING THE COMPENSATION AGREEMENT. THE RECORD IS KEPT BY THE SECRETARY OF THE FOUNDATION.
PART VI, SECTION C, LINE19-AVAILABILTY OF DOCUMENTS, POLICIES, AND F/S:THE FOUNDATION MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE TO THE PUBLIC UPON REQUEST. THE FINANCIAL STATEMENTS ARE ALSO AVAILABLE ON THE FOUNDATION'S WEBSITE.
PART IX, LINE 26, JOINT COSTS ALLOCATION:NFCR IS COMMITTED TO EFFICIENCY AND TRANSPARENCY. FOR MORE THAN 40 YEARS, NFCR HAS BEEN COMMUNICATING WITH SUPPORTERS, DONORS, AND PROSPECTIVE DONORS BY POSTAL MAIL, EMAIL, PHONE, WEBSITE AND OTHER MEANS, BOTH TO REQUEST CONTRIBUTIONS AND TO EDUCATE THE PUBLIC, THEREBY UPHOLDING NFCR'S MISSION STATEMENT ABOUT CANCER AND UPHOLD ITS MISSION, AND AT THE SAME TIME TO PROVIDE FUNDRAISING OPPORTUNITIES. THE COSTS RELATED TO THESE JOINT ACTIVITIES ARE ALLOCATED, THEREBY UPHOLDING NFCR'S MISSION STATEMENT (TO SUPPORT CANCER RESEARCH AND PUBLIC EDUCATION RELATING TO THE PREVENTION, EARLY DIAGNOSIS, BETTER TREATMENTS AND ULTIMATELY, A CURE FOR CANCER). THESE FREE PUBLICATIONS ARE SENT TO TENS OF MILLIONS OF FAMILIES AND INCLUDE MATERIALS SUCH AS EARLY DETECTION GUIDES, CHILDHOOD CANCER CHARTS, CANCER PREVENTION KITS AND RECIPES FOR HEALTHY LIVING. AS A RESULT, IN ACCORDANCE WITH THE FINANCIAL ACCOUNTING STANDARDS BOARD (FASB) GUIDELINES SOP 98-2 (ASC 958-720), WE ALLOCATE A PORTION OF OUR DIRECT MAIL COST TO PROGRAM SERVICES AND TO FUNDRAISING.

Schedule R IRS990ScheduleR

Id Related Tax Exempt Org IdRelatedTaxExemptOrgGrp (2 entries)

Address Line1USAddress/AddressLine1TxtCityUSAddress/CityNmState AbbreviationUSAddress/StateAbbreviationCdZIPUSAddress/ZIPCdEINEINPrimary ActivitiesPrimaryActivitiesTxtLegal Domicile StateLegalDomicileStateCdExempt Code SectionExemptCodeSectionTxtPublic Charity StatusPublicCharityStatusTxtBusiness Name Line1DirectControllingEntityName/BusinessNameLine1TxtControlled OrganizationControlledOrganizationInd
DARWIN FOUNDATION
5515 SECURITY LANE SUITE 1105ROCKVILLEMD20852371473821CANCER RSRCHDC501(C)3509(A)(3)NFCRYes (true)
RESEARCH FOR A CURE
5515 SECURITY LANE SUITE 1105ROCKVILLEMD20852010744146CANCER RSRCHDC501(C)3509(A)(3)NFCRYes (true)
FieldValueIRS element (for citing)
Receipt Of Int Annts Rnts RyltsfalseReceiptOfIntAnntsRntsRyltsInd
Gift Grnt Or Cap Contri To Oth OrgfalseGiftGrntOrCapContriToOthOrgInd
Gift Grnt Cap Contri From Oth OrgfalseGiftGrntCapContriFromOthOrgInd
Loans Or Guarantees To Other OrgfalseLoansOrGuaranteesToOtherOrgInd
Loans Or Guarantees From Oth OrgfalseLoansOrGuaranteesFromOthOrgInd
Div Related OrganizationfalseDivRelatedOrganizationInd
Asset Sale To Other OrgfalseAssetSaleToOtherOrgInd
Asset Purchase From Other OrgfalseAssetPurchaseFromOtherOrgInd
Asset ExchangefalseAssetExchangeInd
Rental Of Facilities To Oth OrgfalseRentalOfFacilitiesToOthOrgInd
Rental Of Fclts From Oth OrgfalseRentalOfFcltsFromOthOrgInd
Perform Of Services For Oth OrgfalsePerformOfServicesForOthOrgInd
Perform Of Services By Other OrgfalsePerformOfServicesByOtherOrgInd
Sharing Of FacilitiesfalseSharingOfFacilitiesInd
Paid Employees SharingfalsePaidEmployeesSharingInd
Reimbursement Paid To Other OrgfalseReimbursementPaidToOtherOrgInd
Reimbursement Paid By Other OrgfalseReimbursementPaidByOtherOrgInd
Transfer To Other OrgfalseTransferToOtherOrgInd
Transfer From Other OrgfalseTransferFromOtherOrgInd